Protagonist Therapeutics
Protagonist Therapeutics:
Proprietary peptide technology platform to develop oral targeted therapy-based drugs and injectables for rare diseases. PTG-300 injectable hepcidin mimetic Ph 2 trials ongoing in polycythemia vera and hereditary hemochromatosis; positive updated Ph 2 results in PV presented at ASH 2020. PN-943 oral GI-restricted alpha-4-beta-7 antagonist Ph 2 in ulcerative colitis study sites activated; PTG-200, partnered w/ Janssen, oral GI-restricted IL-23R antagonist Ph 2 Crohn’s disease study ongoing.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Pacific
Clinical Stage
Phase l or ll
Disease Space
Anti-inflammatory, Autoimmune, Gastrointestinal, Rare Disease
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Public, USA
Market Cap
1B +
Therapeutic Modalities
Platform Technology
Website:
Address:
521 Cottonwood Drive
Suite 100
Milpitas, CA 95035
United States
Suite 100
Milpitas, CA 95035
United States
Presentation:
More info:
My account:
Company Participants at Protagonist Therapeutics PTG-300 Opportunity Update Webinar
- Dinesh V Patel, PhD, President & CEO
Top 10 Holders of Protagonist Therapeutics, Inc.
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| Fidelity Management & Research Co. LLC | 23.38 | 6,413,749 | 166.69 | 13F | 12/31/20 |
| BVF, Inc. | 15.58 | 4,273,588 | 111.07 | 13F | 12/31/20 |
| BVF Partners LP | 15.58 | 4,273,588 | 111.07 | Stakes | 12/31/20 |
| RTW Investments LP | 13.30 | 3,650,069 | 94.87 | Stakes | 12/31/20 |
| Consonance Capital Management LP | 9.95 | 2,729,709 | 70.95 | 13F | 12/31/20 |
| Johnson & Johnson Innovation JJDC, Inc. | 8.93 | 2,449,183 | 63.65 | 13F | 12/31/20 |
| Farallon Capital Management LLC | 8.84 | 2,425,000 | 63.03 | Stakes | 12/31/20 |
| The Vanguard Group, Inc. | 7.29 | 1,999,984 | 51.98 | Funds | 2/28/21 |
| Vanguard Group, Inc. (Subfiler) | 6.97 | 1,912,272 | 49.70 | 13F | 12/31/20 |
| BlackRock Fund Advisors | 5.46 | 1,496,659 | 38.90 | 13F | 12/31/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.